Results

1–10 of 26 results for retinal fluid

Faricimab Rapidly Improves Fluid Parameters in Patients With nAMD
Nikolas JS London, MD, FACS, FASRS
Annual Meeting Talks
2023
Time to Retinal Fluid Control With Faricimab vs Aflibercept in Patients With DME in the Phase 3 YOSEMITE/RHINE Trials
Aleksandra V. Rachitskaya, MD, FASRS
Annual Meeting Talks
2023
Medical Case Conference: Narciso Atienza, MD, MBA, FASRS, FPCS, FPAO
Narciso F. Atienza, MD, MBA, FASRS, FPCS, FPAO.
Annual Meeting Talks
2024
Transretinal Subretinal Fluid Injection Technique for Refractory or Chronic Large Macular Holes
Gregory D Lee, MD
Annual Meeting Talks
2022
Two-Year Evaluation of Subretinal Fluid Drainage Techniques in Pars Plana Vitrectomy for Primary Rhegmatogenous Retinal Detachment (ELLIPSOID-2 Study)
Bryon McKay, MD, PhD, FRCSC
Annual Meeting Talks
2022
AI-Based Spatiotemporal Observations of Retinal Fluid Dynamics Using the Notal Vision Home OCT
Anat Loewenstein, MD
Annual Meeting Talks
2022
End-of-Study Retinal Fluid and Vision Outcomes in the Archway Phase 3 Trial of the Port Delivery System With Ranibizumab in Patients With nAMD
Aleksandra V. Rachitskaya, MD, FASRS
Annual Meeting Talks
2022
Outcomes of Subretinal Fluid Drainage Methods in Pars Plana Vitrectomy for Primary Retinal Detachment
Jose J Echegaray, MD
On Demand Cases, Courses, and Papers
2021
Persistent Subretinal Fluid Following Diabetic Tractional Retinal Detachment Repair: Risk Factors, Natural History, and Management Outcomes
Ahmed Algethami, MD
On Demand Cases, Courses, and Papers
2021
Impact of Duration of Exposure to Residual Intraretinal Fluid on Visual Function Outcomes in Neovascular Age-Related Macular Degeneration (nAMD)
Nathan C. Steinle, MD
On Demand Cases, Courses, and Papers
2021